Zacks Investment Research
10 Aug 2026, 22:56 UTC · 1d ago
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
10 Aug 2026, 22:56 UTC · 1d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Orchestra BioMed Holdings (OBIO) reported quarterly revenues of $0.09 million, missing consensus estimates by 32.31%. — A significant revenue miss, especially compared to $0.84 million a year ago, indicates a severe decline in business performance.
-0.60Orchestra BioMed Holdings reported a quarterly loss of $0.38 per share, wider than the estimated loss of $0.35. — The earnings miss represents a negative surprise of -8.57%, reflecting higher-than-expected losses.
-0.40Which stocks this story touches
The company reported a quarterly loss and revenue that missed consensus estimates.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
52m ago
